We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+4.4%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$667M
AUM Growth
-$156M
Cap. Flow
+$83.2M
Cap. Flow %
12.47%
Top 10 Hldgs %
36.65%
Holding
203
New
66
Increased
38
Reduced
28
Closed
61

Top Buys

Rank Stock Value
1
TBT icon
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
+$42.5M
2
CELG
Celgene Corp
CELG
+$21.6M
3
ELV icon
Elevance Health
ELV
+$18.4M
4
RUN icon
Sunrun
RUN
+$13.1M
5
ASH icon
Ashland
ASH
+$9.72M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$20.1M
2
NSM
Nationstar Mortgage Holdings
NSM
+$11.6M
3
MAC icon
Macerich
MAC
+$11.6M
4
NGD
New Gold Inc
NGD
+$10.4M
5
HASI icon
Hannon Armstrong Sustainable Infrastructure Capital
HASI
+$9.42M

Sector Composition

Rank Sector Weight
1 Healthcare 23.53%
2 Miscellaneous 21.87%
3 Technology 20.83%
4 Utilities 9.14%
5 Materials 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMD icon
101
CALL
Advanced Micro Devices
AMD
$843B
$503K 0.08%
+50,000
New +$593K
AMD icon
102
Advanced Micro Devices
AMD
$843B
$503K 0.08%
50,000
+10,000
+25% +$119K
FDX icon
103
FedEx
FDX
$73.8B
$480K 0.07%
+2,000
New +$506K
QTNT
104
DELISTED
Quotient Limited Ordinary Shares
QTNT
$471K 0.07%
+2,500
New +$451K
NVDA icon
105
NVIDIA
NVDA
$5.27T
$465K 0.07%
80,000
+20,000
+33% +$117K
CERS icon
106
Cerus
CERS
$502M
$438K 0.07%
80,000
– –
ABEO icon
107
Abeona Therapeutics
ABEO
$310M
$428K 0.06%
1,200
-400
-25% -$149K
ATRC icon
108
AtriCure
ATRC
$2.77B
$410K 0.06%
20,000
+2,500
+14% +$45.1K
VISN
109
Vistance Networks Inc
VISN
$1.49B
$400K 0.06%
+10,000
New +$390K
ACER
110
DELISTED
Acer Therapeutics Inc
ACER
$386K 0.06%
20,000
+4,700
+31% +$86.1K
PYPL icon
111
PayPal
PYPL
$46B
$379K 0.06%
+5,000
New +$397K
HDS
112
DELISTED
HD Supply Holdings, Inc.
HDS
$379K 0.06%
+10,000
New +$377K
GS icon
113
Goldman Sachs
GS
$300B
$378K 0.06%
+1,500
New +$391K
XLNX
114
DELISTED
Xilinx Inc
XLNX
$361K 0.05%
+5,000
New +$360K
ACRS icon
115
Aclaris Therapeutics
ACRS
$783M
$350K 0.05%
+20,000
New +$424K
MGM icon
116
MGM Resorts International
MGM
$10B
$350K 0.05%
+10,000
New +$351K
PTE
117
DELISTED
PolarityTE, Inc. Common Stock
PTE
$346K 0.05%
764
+200
+35% +$101K
THS
118
DELISTED
Treehouse Foods
THS
$344K 0.05%
+9,000
New +$392K
XOG
119
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
$344K 0.05%
+30,000
New +$398K
ENPH icon
120
Enphase Energy
ENPH
$4.8B
$343K 0.05%
+75,000
New +$228K
TLND
121
DELISTED
Talend S.A. American Depositary Shares
TLND
$337K 0.05%
+7,000
New +$298K
ALDX icon
122
Aldeyra Therapeutics
ALDX
$80.8M
$336K 0.05%
45,000
– –
CHRS icon
123
Coherus Oncology
CHRS
$205M
$332K 0.05%
+30,000
New +$328K
JPM icon
124
JPMorgan Chase
JPM
$947B
$330K 0.05%
+3,000
New +$340K
REGI
125
DELISTED
Renewable Energy Group, Inc.
REGI
$319K 0.05%
+25,000
New +$281K
3 4
5
6 7

Similar funds

RAM
Ramirez Asset Management New York $960M AUM 30.25% 1-Year Est. Return
JWBC
J.W. Burns & Co Dewitt, New York $959M AUM 25.08% 1-Year Est. Return
PL
Parthenon LLC Louisville, Kentucky $962M AUM 27.46% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $962M AUM 35.11% 1-Year Est. Return
WI
Wahed Invest New York $958M AUM 66.65% 1-Year Est. Return
LAM
L2 Asset Management Wayland, Massachusetts $963M AUM 38.06% 1-Year Est. Return
ACP
Aviance Capital Partners Naples, Florida $963M AUM 32.56% 1-Year Est. Return

Ardsley Advisory Partners's Q1 2018 Portfolio in Review

As of Q1 2018, Ardsley Advisory Partners held 203 positions worth $667M, down 19% from $823M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Ardsley Advisory Partners deployed $83.2M of net new capital in Q1 2018, opening 66 new positions and adding to 38 existing holdings. Its largest new stake was Celgene Corp: 224,500 shares worth $20M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 17% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was Macerich, an estimated $11.6M trimmed.

  • Ardsley Advisory Partners's largest Q1 2018 buy was Celgene Corp: 224,500 shares worth $20M.
  • Ardsley Advisory Partners added most to ProShares Trust UltraShort Lehman 20+ Year Treasury in Q1 2018, an estimated $42.5M increase.
  • Ardsley Advisory Partners's biggest Q1 2018 reduction was Macerich, cutting an estimated $11.6M.
  • Ardsley Advisory Partners fully exited AbbVie in Q1 2018, selling an estimated $20.1M.
  • Ardsley Advisory Partners's ten largest holdings make up 37% of its $667M portfolio in Q1 2018.
  • Ardsley Advisory Partners opened 66 new positions and closed 61 in Q1 2018.
  • Ardsley Advisory Partners's portfolio value fell 19% quarter-over-quarter to $667M.

Based on Ardsley Advisory Partners's 13F filing for Q1 2018, filed 15 May 2018.